Christopher Twitty insider trades

Open-market stock purchases and sales by Christopher Twitty, Chief Scientific Officer at Skye Bioscience, Inc, from SEC Form 4 filings since Jan 6, 2022.

Recent trades

DateStockTradeValue
Mar 31, 2026SKYE Skye Bioscience, IncSold (not open market)$434K
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)$7.4K
Mar 31, 2026SKYE Skye Bioscience, IncSold (not open market)$51K
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)$10.5K
Mar 31, 2026SKYE Skye Bioscience, IncSold (not open market)$59.5K
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)$45.8K
Mar 31, 2026SKYE Skye Bioscience, IncSold (not open market)$1.1M
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)$4.4K
Mar 31, 2026SKYE Skye Bioscience, IncSold (not open market)$24.9K
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)$123K
Mar 31, 2026SKYE Skye Bioscience, IncSold (not open market)$1M
Mar 31, 2026SKYE Skye Bioscience, IncBought (not open market)$92.3K
Feb 6, 2026SKYE Skye Bioscience, IncBought (not open market)—

Companies traded

  • SKYE Skye Bioscience, Inc: other filings, last Mar 31, 2026
  • LSPR Larkspur Health Acquisition Corp: other filings, last Jan 6, 2022

Get free alerts when Christopher Twitty files a new trade →